SC 13G Filing

Company

SUTRO BIOPHARMA, INC.

Filed

April 5, 2024

Accession Number

0000902664-24-002770

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →